Printer Friendly

India : Anti-Diabetic Drug Ayush-82 to be commercialised.

The National Research Development Corporation(NRDC) of the Department of Scientific & Industrial Research, Ministry of Science & Technology signed a License Agreement with Kudos Laboratories India for commercialization of Ayush-82, an ayurvedic formulation for prevention and management of Diabetes.

It has been developed by Central Council for Research in Ayurvedic Sciences (CCRAS), New Delhi, an apex organization for research in Ayurveda under the Ministry of AYUSH (Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homeopathy).

Chairman & Managing Director NRDC, Dr. H. Purushotham, Prof. Vd. K.S. Dhiman, Director General of CCRAS and Senior Executives/Scientists of NRDC and CCRAS were also present during the event. Prof. Dhiman highlighted about the formulation and its benefits. Dr. H. Purushotham said that patients are preferring Ayurvedic drugs as it can be seen that in the recent past NRDC licensed 12 Ayurvedic drugs developed by CCRAS to 32 companies in India.

Now Kudos Laboratories India could commercialize this product under their trade name with due acknowledgement to CCRAS, Ministry of AYUSH, Government of India.

[c] 2016 Al Bawaba (Albawaba.com) Provided by SyndiGate Media Inc. ( Syndigate.info ).

COPYRIGHT 2016 SyndiGate Media Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2016 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Mena Report
Geographic Code:9INDI
Date:Mar 17, 2016
Words:180
Previous Article:India : Skill Development in Aviation Sector.
Next Article:India : Reservation for SCs and STs in Allotment of Shops/Stalls at Railway Stations.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters